Asia Pacific Influenza Diagnostics Market Size study, by Test Type (RIDT, RT-PCR, Cell Culture, Others), by End Use (Hospitals, POCT, Laboratories) and Country Forecasts 2022-2032
Asia Pacific Influenza Diagnostics Market is valued at approximately USD 330 million in 2023 and is anticipated to grow with a healthy growth rate of more than 7.86% over the forecast period 2024-2032. Influenza diagnostics refers to the methods and technologies used to identify and diagnose influenza virus infections in persons. These diagnostics are critical to public health as they enable early detection, treatment, and prevention of influenza transmission. Moreover, there has been a growing demand for POCT (Point-of-Care Testing) devices in the Asia Pacific region due to their ability to provide rapid and accurate results, especially in remote and resource-limited settings. POCT devices offer advantages such as quick turnaround time, ease of use, and minimal sample processing requirements, making them increasingly popular for influenza diagnosis, this anticipated to support the Influenza Diagnostics Market.
Moreover, the Asia Pacific region, with its dense population and varied climates, often experiences influenza outbreaks. The rising incidence of influenza drives the demand for diagnostics to accurately identify and manage cases. Also, governments and healthcare authorities in many Asia Pacific countries are implementing various initiatives to control and prevent the spread of influenza. These initiatives often include vaccination campaigns and investments in diagnostic infrastructure, which contribute to market growth. Additionally, other factors that support the market growth are growing awareness and healthcare infrastructure, supportive government initiatives, increasing research and development activities, growing research and development activities, rising demand for point-of-care testing, and increasing healthcare spending. However, the lack of skilled professionals, and stringent regulatory frameworks are anticipated to hinder the market growth during the forecast period 2024-2032.
The key Countries considered for the Asia Pacific Influenza Diagnostics market study includes China, India, Japan, South Korea, Australia and Rest of Asia Pacific. In 2023, China was the largest regional market. The Chinese government has been actively promoting healthcare infrastructure development and disease control measures. Initiatives aimed at controlling infectious diseases such as influenza drive the adoption of diagnostic tests. Also, with the rise in population density and increased globalization, the spread of influenza viruses has become more common. This increases the demand for diagnostic tests to identify and manage outbreaks effectively. Moreover, India is expected to grow with the highest CAGR during the forecast period 2024-2032.
Major market player included in this report are:
Abbott Laboratories
SD Biosensor Inc
3B BlackBio Dx Limited
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
The detailed segments and sub-segment of the market are explained below:
By Test Type
RIDT
RT-PCR
Cell Culture
Others
By End Use
Hospitals
POCT
Laboratories
By Region:
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market
Moreover, the Asia Pacific region, with its dense population and varied climates, often experiences influenza outbreaks. The rising incidence of influenza drives the demand for diagnostics to accurately identify and manage cases. Also, governments and healthcare authorities in many Asia Pacific countries are implementing various initiatives to control and prevent the spread of influenza. These initiatives often include vaccination campaigns and investments in diagnostic infrastructure, which contribute to market growth. Additionally, other factors that support the market growth are growing awareness and healthcare infrastructure, supportive government initiatives, increasing research and development activities, growing research and development activities, rising demand for point-of-care testing, and increasing healthcare spending. However, the lack of skilled professionals, and stringent regulatory frameworks are anticipated to hinder the market growth during the forecast period 2024-2032.
The key Countries considered for the Asia Pacific Influenza Diagnostics market study includes China, India, Japan, South Korea, Australia and Rest of Asia Pacific. In 2023, China was the largest regional market. The Chinese government has been actively promoting healthcare infrastructure development and disease control measures. Initiatives aimed at controlling infectious diseases such as influenza drive the adoption of diagnostic tests. Also, with the rise in population density and increased globalization, the spread of influenza viruses has become more common. This increases the demand for diagnostic tests to identify and manage outbreaks effectively. Moreover, India is expected to grow with the highest CAGR during the forecast period 2024-2032.
Major market player included in this report are:
Abbott Laboratories
SD Biosensor Inc
3B BlackBio Dx Limited
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
The detailed segments and sub-segment of the market are explained below:
By Test Type
RIDT
RT-PCR
Cell Culture
Others
By End Use
Hospitals
POCT
Laboratories
By Region:
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market
CHAPTER 1. ASIA PACIFIC INFLUENZA DIAGNOSTICS MARKET DEFINITION AND RESEARCH ASSUMPTIONS
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Asia Pacific Influenza Diagnostics Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Test Type
2.3.2. By End Use
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
CHAPTER 3. ASIA PACIFIC INFLUENZA DIAGNOSTICS MARKET DYNAMICS
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
CHAPTER 4. ASIA PACIFIC INFLUENZA DIAGNOSTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. ASIA PACIFIC INFLUENZA DIAGNOSTICS MARKET SIZE & FORECASTS BY TEST TYPE 2022-2032
5.1. RIDT
5.2. RT-PCR
5.3. Cell Culture
5.4. Others
CHAPTER 6. ASIA PACIFIC INFLUENZA DIAGNOSTICS MARKET SIZE & FORECASTS BY END USE 2022-2032
6.1. Hospitals
6.2. POCT
6.3. Laboratories
CHAPTER 7. ASIA PACIFIC INFLUENZA DIAGNOSTICS MARKET SIZE & FORECASTS BY COUNTRY 2022-2032
7.1. China Influenza Diagnostics Market
7.1.1. Test Type breakdown size & forecasts, 2022-2032
7.1.2. End Use breakdown size & forecasts, 2022-2032
7.2. India Influenza Diagnostics Market
7.3. Japan Influenza Diagnostics Market
7.4. Australia Influenza Diagnostics Market
7.5. South Korea Influenza Diagnostics Market
7.6. Rest of Asia Pacific Influenza Diagnostics Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Company
8.1.2. Company
8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Abbott Laboratories
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. SD Biosensor Inc
8.3.3. 3B BlackBio Dx Limited
8.3.4. Company
8.3.5. Company
8.3.6. Company
8.3.7. Company
8.3.8. Company
8.3.9. Company
8.3.10. Company
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Asia Pacific Influenza Diagnostics Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Test Type
2.3.2. By End Use
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
CHAPTER 3. ASIA PACIFIC INFLUENZA DIAGNOSTICS MARKET DYNAMICS
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
CHAPTER 4. ASIA PACIFIC INFLUENZA DIAGNOSTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. ASIA PACIFIC INFLUENZA DIAGNOSTICS MARKET SIZE & FORECASTS BY TEST TYPE 2022-2032
5.1. RIDT
5.2. RT-PCR
5.3. Cell Culture
5.4. Others
CHAPTER 6. ASIA PACIFIC INFLUENZA DIAGNOSTICS MARKET SIZE & FORECASTS BY END USE 2022-2032
6.1. Hospitals
6.2. POCT
6.3. Laboratories
CHAPTER 7. ASIA PACIFIC INFLUENZA DIAGNOSTICS MARKET SIZE & FORECASTS BY COUNTRY 2022-2032
7.1. China Influenza Diagnostics Market
7.1.1. Test Type breakdown size & forecasts, 2022-2032
7.1.2. End Use breakdown size & forecasts, 2022-2032
7.2. India Influenza Diagnostics Market
7.3. Japan Influenza Diagnostics Market
7.4. Australia Influenza Diagnostics Market
7.5. South Korea Influenza Diagnostics Market
7.6. Rest of Asia Pacific Influenza Diagnostics Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Company
8.1.2. Company
8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Abbott Laboratories
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. SD Biosensor Inc
8.3.3. 3B BlackBio Dx Limited
8.3.4. Company
8.3.5. Company
8.3.6. Company
8.3.7. Company
8.3.8. Company
8.3.9. Company
8.3.10. Company
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
LIST OF TABLES
TABLE 1. Asia Pacific Influenza Diagnostics market, report scope
TABLE 2. Asia Pacific Influenza Diagnostics market estimates & forecasts by Country 2022-2032 (USD Million)
TABLE 3. Asia Pacific Influenza Diagnostics market estimates & forecasts by Test Type 2022-2032 (USD Million)
TABLE 4. Asia Pacific Influenza Diagnostics market estimates & forecasts by End Use 2022-2032 (USD Million)
TABLE 5. Asia Pacific Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 6. Asia Pacific Influenza Diagnostics market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 7. Asia Pacific Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 8. Asia Pacific Influenza Diagnostics market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 9. Asia Pacific Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 10. Asia Pacific Influenza Diagnostics market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 11. Asia Pacific Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 12. Asia Pacific Influenza Diagnostics market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 13. Asia Pacific Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 14. Asia Pacific Influenza Diagnostics market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 15. China Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 16. China Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 17. China Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 18. India Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 19. India Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 20. India Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 21. Japan Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 22. Japan Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 23. Japan Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 24. Australia Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 25. Australia Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 26. Australia Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 27. South Korea Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 28. South Korea Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 29. South Korea Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 30.
TABLE 31. RoAPAC Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 32. RoAPAC Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 33. RoAPAC Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 34. List of secondary sources, used in the study of Asia Pacific Influenza Diagnostics Market.
TABLE 35. List of primary sources, used in the study of Asia Pacific Influenza Diagnostics Market.
TABLE 36. Years considered for the study.
TABLE 37. Exchange rates considered
TABLE 1. Asia Pacific Influenza Diagnostics market, report scope
TABLE 2. Asia Pacific Influenza Diagnostics market estimates & forecasts by Country 2022-2032 (USD Million)
TABLE 3. Asia Pacific Influenza Diagnostics market estimates & forecasts by Test Type 2022-2032 (USD Million)
TABLE 4. Asia Pacific Influenza Diagnostics market estimates & forecasts by End Use 2022-2032 (USD Million)
TABLE 5. Asia Pacific Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 6. Asia Pacific Influenza Diagnostics market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 7. Asia Pacific Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 8. Asia Pacific Influenza Diagnostics market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 9. Asia Pacific Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 10. Asia Pacific Influenza Diagnostics market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 11. Asia Pacific Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 12. Asia Pacific Influenza Diagnostics market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 13. Asia Pacific Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 14. Asia Pacific Influenza Diagnostics market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 15. China Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 16. China Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 17. China Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 18. India Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 19. India Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 20. India Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 21. Japan Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 22. Japan Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 23. Japan Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 24. Australia Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 25. Australia Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 26. Australia Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 27. South Korea Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 28. South Korea Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 29. South Korea Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 30.
TABLE 31. RoAPAC Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 32. RoAPAC Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 33. RoAPAC Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 34. List of secondary sources, used in the study of Asia Pacific Influenza Diagnostics Market.
TABLE 35. List of primary sources, used in the study of Asia Pacific Influenza Diagnostics Market.
TABLE 36. Years considered for the study.
TABLE 37. Exchange rates considered
LIST OF FIGURES
FIG 1. Asia Pacific Influenza Diagnostics market, research methodology
FIG 2. Asia Pacific Influenza Diagnostics market, market estimation techniques
FIG 3. Asia Pacific market size estimates & forecast methods.
FIG 4. Asia Pacific Influenza Diagnostics market, key trends 2023
FIG 5. Asia Pacific Influenza Diagnostics market, growth prospects 2022-2032
FIG 6. Asia Pacific Influenza Diagnostics market, porters 5 force model
FIG 7. Asia Pacific Influenza Diagnostics market, pestel analysis
FIG 8. Asia Pacific Influenza Diagnostics market, value chain analysis
FIG 9. Asia Pacific Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 10. Asia Pacific Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 11. Asia Pacific Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 12. Asia Pacific Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 13. Asia Pacific Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 14. Asia Pacific Influenza Diagnostics market, Country snapshot 2022 & 2032
FIG 15. Asia pacific Influenza Diagnostics market 2022 & 2032 (USD Million)
FIG 16. Asia Pacific Influenza Diagnostics market, company market share analysis (2023)
FIG 1. Asia Pacific Influenza Diagnostics market, research methodology
FIG 2. Asia Pacific Influenza Diagnostics market, market estimation techniques
FIG 3. Asia Pacific market size estimates & forecast methods.
FIG 4. Asia Pacific Influenza Diagnostics market, key trends 2023
FIG 5. Asia Pacific Influenza Diagnostics market, growth prospects 2022-2032
FIG 6. Asia Pacific Influenza Diagnostics market, porters 5 force model
FIG 7. Asia Pacific Influenza Diagnostics market, pestel analysis
FIG 8. Asia Pacific Influenza Diagnostics market, value chain analysis
FIG 9. Asia Pacific Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 10. Asia Pacific Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 11. Asia Pacific Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 12. Asia Pacific Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 13. Asia Pacific Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 14. Asia Pacific Influenza Diagnostics market, Country snapshot 2022 & 2032
FIG 15. Asia pacific Influenza Diagnostics market 2022 & 2032 (USD Million)
FIG 16. Asia Pacific Influenza Diagnostics market, company market share analysis (2023)
